Excellus Bluecross BlueShield logo
Login | Register | Forgot Username | Forgot Password
Program Offerings
By Phone
By Email
By Mail
Visit Us In-Person
News & Updates
Print Forms
About Us
Compliance Notices
Employer News | June 24, 2014
Employer News | June 24, 2014

Support Materials Now Available for the "Take As Directed" Campaign

As you may know, Excellus BlueCross BlueShield has launched a community engagement campaign based around a super hero prescription bottle called TAD, for “Take As Directed.” The TAD super hero conveys the message “it’s super if you take it.” 

When it comes to fighting chronic conditions, a prescription drug can be a super hero. But it only works if you take it. If you have a chronic condition like high blood pressure or high cholesterol, taking your prescriptions as directed - which is also known as medication adherence - is essential to healthy living.

The American Heart Association says poor medication adherence takes 125,000 lives in the U.S. annually and costs the health care system nearly $300 billion a year in additional doctor and emergency department visits and hospitalizations.

Several "TAD" support materials are now available to share with employees and around your organization.

Flyer: B-4682 (PDF) | Poster: B-4681 (PDF) | Payroll Stuffer: B-4683 (PDF) | Info Sheet: B-4720 (PDF)

To request printed copies, please contact your Account Consultant and reference the "B-xxxx" number next to each link.

Learn more about the TAD campaign, saving with generic drugs, and more.


Home     News & Updates    Print Forms    About Us    Fraud & Abuse    Glossary    Accreditations   
Copyright © 2015, Excellus BlueCross BlueShield, a nonprofit independent licensee of the Blue Cross Blue Shield Association. All rights reserved. View our Privacy Policy for information on how we protect your privacy. Use of this site indicates your acceptance of our Terms of Use. Follow this link to view our 31 county New York State service area. You will need Internet Explorer or Firefox to use the secure features of this site.